These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33799222)

  • 21. Antitumor activity of the synthetic retinoid ST1926 on primary effusion lymphoma in vitro and in vivo models.
    Karam L; Houshaymi B; Abdel-Samad R; Jaafar M; Halloum I; Pisano C; Neipel F; Darwiche N; Abou Merhi R
    Oncol Rep; 2018 Feb; 39(2):721-730. PubMed ID: 29207182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma.
    Qin Z; Dai L; Trillo-Tinoco J; Senkal C; Wang W; Reske T; Bonstaff K; Del Valle L; Rodriguez P; Flemington E; Voelkel-Johnson C; Smith CD; Ogretmen B; Parsons C
    Mol Cancer Ther; 2014 Jan; 13(1):154-64. PubMed ID: 24140934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression Ratios of the Antiapoptotic BCL2 Family Members Dictate the Selective Addiction of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Primary Effusion Lymphoma Cell Lines to MCL1.
    Dunham D; Viswanathan P; Gill J; Manzano M
    J Virol; 2022 Dec; 96(23):e0136022. PubMed ID: 36416587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma.
    Goto H; Kudo E; Kariya R; Taura M; Katano H; Okada S
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):465-74. PubMed ID: 25304617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hippuristanol reduces the viability of primary effusion lymphoma cells both in vitro and in vivo.
    Ishikawa C; Tanaka J; Katano H; Senba M; Mori N
    Mar Drugs; 2013 Sep; 11(9):3410-24. PubMed ID: 24018901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulforaphane Exhibits Cytotoxic Effects against Primary Effusion Lymphoma Cells by Suppressing p38MAPK and AKT Phosphorylation.
    Ishiura Y; Ishimaru H; Watanabe T; Fujimuro M
    Biol Pharm Bull; 2019; 42(12):2109-2112. PubMed ID: 31787726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma.
    Paul AG; Sharma-Walia N; Chandran B
    PLoS One; 2011; 6(9):e24379. PubMed ID: 21980345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hybrid liposomes inhibit the growth of primary effusion lymphoma in vitro and in vivo.
    Towata T; Komizu Y; Suzu S; Matsumoto Y; Ueoka R; Okada S
    Leuk Res; 2010 Jul; 34(7):906-11. PubMed ID: 20074798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma.
    Bhatt S; Ashlock BM; Toomey NL; Diaz LA; Mesri EA; Lossos IS; Ramos JC
    J Clin Invest; 2013 Jun; 123(6):2616-28. PubMed ID: 23635777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma.
    Gopalakrishnan R; Matta H; Choi S; Chaudhary PM
    Sci Rep; 2020 Mar; 10(1):5712. PubMed ID: 32235878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
    Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
    PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic analysis of a xenograft mice model for KSHV+ primary effusion lymphoma (PEL).
    Dai L; Trillo-Tinoco J; Bai L; Kang B; Xu Z; Wen X; Del Valle L; Qin Z
    PLoS One; 2014; 9(2):e90349. PubMed ID: 24587336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma.
    Caro-Vegas C; Bailey A; Bigi R; Damania B; Dittmer DP
    mBio; 2019 Feb; 10(1):. PubMed ID: 30782662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
    Seltzer J; Moorad R; Schifano JM; Landis JT; Dittmer DP
    J Virol; 2020 May; 94(10):. PubMed ID: 32161170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma.
    Goto H; Kojima Y; Matsuda K; Kariya R; Taura M; Kuwahara K; Nagai H; Katano H; Okada S
    Eur J Cancer; 2014 Jul; 50(10):1836-1846. PubMed ID: 24726056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient inhibition of NF-kappaB by DHMEQ induces cell death of primary effusion lymphoma without HHV-8 reactivation.
    Dabaghmanesh N; Matsubara A; Miyake A; Nakano K; Ishida T; Katano H; Horie R; Umezawa K; Watanabe T
    Cancer Sci; 2009 Apr; 100(4):737-46. PubMed ID: 19469019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A role for MALT1 activity in Kaposi's sarcoma-associated herpes virus latency and growth of primary effusion lymphoma.
    Bonsignore L; Passelli K; Pelzer C; Perroud M; Konrad A; Thurau M; Stürzl M; Dai L; Trillo-Tinoco J; Del Valle L; Qin Z; Thome M
    Leukemia; 2017 Mar; 31(3):614-624. PubMed ID: 27538487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nigericin Induces Apoptosis in Primary Effusion Lymphoma Cells by Mitochondrial Membrane Hyperpolarization and β-Catenin Destabilization.
    Umeyama H; Shigemi Z; Baba Y; Hara N; Watanabe T; Fujimuro M
    Anticancer Res; 2023 Jun; 43(6):2455-2465. PubMed ID: 37247906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of human herpesvirus 8 interleukin-6-activated gp130 signal transducer in primary effusion lymphoma cell growth and viability.
    Cousins E; Nicholas J
    J Virol; 2013 Oct; 87(19):10816-27. PubMed ID: 23903842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells.
    Saji C; Higashi C; Niinaka Y; Yamada K; Noguchi K; Fujimuro M
    Biochem Biophys Res Commun; 2011 Dec; 415(4):573-8. PubMed ID: 22074820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.